Upexi Raises $7M Via Equity Offering

Upexi Inc (NASDAQ:UPXI) has entered into definitive agreements with institutional and accredited investors for the purchase and sale of 2.1…
  • Upexi Inc (NASDAQ:UPXI) has entered into definitive agreements with institutional and accredited investors for the purchase and sale of 2.1 million shares at $3.30 per share.
  • The offer price represents a 24% discount to the closing price as of May 11.
  • The shares are being sold under a registered direct offering for gross proceeds of approximately $7 million.
  • The closing of the offering is expected to occur on or about May 16, 2023.
  • Also Read: Upexi’s Tytan Tiles Toy Brand Inks Licensing Agreement With Walt Disney
  • Price Action: UPXI shares are trading lower by 16.8% at $3.60 on the last check Friday.
Total
0
Shares
Related Posts
Read More

‘FYARRO, Sirolimus Protein-Bound Particles For Injectable Suspension, Albumin-Bound, FDA Approved For Treatment Of Locally Advanced Unresectable Or Metastatic Malignant Perivascular Epithelioid Cell Tumor, Available At Biologics By McKesson’

https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/2022/FYARRO-FDA-Approved-Treatment-Advanced-Unresectable-Metastatic-Malignant-Perivascular-Epithelioid-Cell-Tumor/ Biologics by McKesson, an independent

MCK

Read More

Microsoft Launches Team Copilot To Boost Workplace Collaboration

Microsoft Corp. (NASDAQ: MSFT) unveiled Team Copilot, an AI assistant designed to enhance team collaboration by taking notes, summarizing key points, and managing deadlines. This launch, part of Microsoft's broader AI strategy, was announced at the annual Build conference. Team Copilot will be available to corporate clients later this year, reinforcing Microsoft's leadership in integrating AI into its productivity tools and cloud services.

AMD